CD14 and tuberculosis: Since increasing proportions of CD14+/HLA-DR+ cells have been associated with increased disease severity (McGill et al., 2022), we sought to also compare their proportions in PBMCs from both controls and cured TB cases for the ethnic groups to eliminate the possible effect of any underlining disease on the study participants (Figures 3A.vi, B.vi).